CSF2 and metabolic dysfunction-associated steatohepatitis: Thus, our study concurs with Morrison et al. (46) since CSF2 was predicted to be inhibited in the liver of rats fed with the SPI diet (Figure 6A) in a pathological state previous to NASH.